Operating margin · 2016–2025
Edwards Lifesciences operating margin
20.8%−17.8% · FY2025
Edwards Lifesciences (EW) reported 20.8% in operating margin for fiscal 2025, −17.8% year on year.
| Fiscal year | Operating margin | Change | Filing |
|---|---|---|---|
| FY2025 | 20.8% | −17.8% | Derived |
| FY2024 | 25.3% | −3.0% | Derived |
| FY2023 | 26.1% | −22.2% | Derived |
| FY2022 | 33.6% | +3.9% | Derived |
| FY2021 | 32.3% | +57.9% | Derived |
| FY2020 | 20.5% | −22.4% | Derived |
| FY2019 | 26.4% | +31.2% | Derived |
| FY2018 | 20.1% | −36.6% | Derived |
| FY2017 | 31.7% | +25.1% | Derived |
| FY2016 | 25.3% | — | Derived |
Operating margin — Operating margin is operating income divided by revenue. Only companies with at least $1 billion in revenue are ranked here.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth −2.2%
Calculated from two reported figures, so it has no single filing of its own.
Operating margin at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Edwards Lifesciences operating margin |url=https://companiesranked.com/en/company/edwards-lifesciences/operating-margin |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Edwards Lifesciences operating margin. CompaniesRanked. https://companiesranked.com/en/company/edwards-lifesciences/operating-marginBibTeX
@misc{companiesranked-en-company-edwards-lifesciences-operating-margin-2026,
author = {{CompaniesRanked}},
title = {{Edwards Lifesciences operating margin}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/edwards-lifesciences/operating-margin}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.